Partnering opportunities

Clinical technology companies looking to collaborate

Business and academia from UK and around the world looking to partner to co-develop clinical technology. We can connect you.

We help ambitious, post-start up businesses, to

  • Move into new markets
  • Access funding
  • Use our networks
  • Innovate to grow
  • Find trusted partners
Innovate UK
HM Government
European Commission

Start new search

99 total opportunities

Filter your results

I’m looking for a partner...
Country of origin

{[{ | number }]} opportunities

99 opportunities

Get updates to this list

The search results below each have a summary which you may find useful in determining if the opportunity is what you’re looking for.

{[{ row.title }]}

{[{ row.summary }]}

Country of origin {[{ }]}

Innovative clinical stage small molecule for liver cancer

The French pharmaceutical company is developing a new oral small molecule targeting the lysosomal compartment of cancer cells, including cancer stem cells. In vitro data confirmed the anti-cancer agent action on many tumor types (colon carcinoma,... more


Allopurinol-based paediatric treatment of autistic disorders proposed by a French clinical research team

A French clinical research team has developped an innovative paediatric treatment for autistic disorders coming from a specific enzym deficiency. The team is represented by a Technology Transfer Office (TTO) which... more


Early treatment of epilepsy in newborn offered by a French clinical research team

A French clinical research team has developed an innovative treatment for paediatric epileptic seizures coming from a vitamin-sensitive effect. This research team is represented by a Technology Transfer Office... more


Ukrainian clinical and research institute is looking for business and manufacturing partners for large-scale production of vaccines based on dendritic cells thought commercial agreement with technical assistance

Ukrainian research and development clinical institution was established in 1920. Now it is the leading organization in the country which conducts cancer research on the basic, translational and clinical... more


French pre-clinical biotech company offers its expertise in drug discovery and repurposing to identify personnalized medicine for patients with rare monogenetic diseases

The French company is a pre-clinical biotech company with a strong expertise in the fild of monogenetic disorders designing and developing miniaturised and automated in vitro cellular and phenotypic assays based... more


A UK SME is looking for neonatal and paediatric hospitals for vital-sign remote monitoring collaboration under a technical cooperation agreement.

24/7 that allow having a clear image of the exact ongoing condition. Although some systems are available for use in clinical settings, there is not yet an option for parents to monitor signs reliably at home.... more

United Kingdom

Intelligent, structured, medical reporting with integrated AI-ready suite that generates machine-readable data for healthcare analytics

Background: The company was founded some years ago as a spin-off from a Southern German university. The company offers a solution for structured medical reporting and clinical guidance. The first platform was launched... more


Actively targeted polymeric micelles for drug and gene delivery

of cancer and other complex diseases with an important genetic background. However, the in vivo delivery of oligonucleotides (OGN) has precluded the clinical use of gene-based therapies mainly due to its vulnerability... more


A Phase 2a-stage drug for Huntington’s disease for license agreement

) orphan disease space—the company’s therapeutic focus. The company’s pipeline consists of clinical-stage assets for Huntington’s disease and Adrenoleukodystrophy, as well as preclinical-stage assets for Adrenomyeloneuropathy,... more


UK-based SME offers novel small molecule for treatment of cancer

Wnt signalling is implicated, such as stonach, liver and pancreatic cancer. Testing on this molecule shows that it displays anti-proliferative activity in pre-clinical in vivo models, has a favourable pharmacokinetic... more

United Kingdom

Targeted anti-cancer drug delivery system.

oral and ocular application. They published over a hundred articles in high-impact scientific journals. Partners are sought to participate with the finalisation of the pre-clinical and/or clinical... more


Molecular oncology diagnostic tool in targeted therapy

The Italian company offers a full range of histology and cytology tests for oncology. Stemming from the clinical experience the molecular tests are based on the choice of the most important genes involved in the... more


GMP (Good manufacturing practice) production of cell therapy products

quality assurance laboratories including cell biology and molecular biology laboratories. Company’s customers include hospitals, biotech and pharmaceutical companies conducting cell therapy-based clinical trials. Regenerative... more


Innovative target therapy for melanoma treatment

early stage melanoma at risk of unexpected progression after surgical treatment or earlier in treatment. Biotechnology and/or pharmaceutical company or SMEs are sought for license or financial agreement. The area of activity of the partner... more


UK-based SME with innovative genetic carrier screen offering the technology to end users for testing and feedback

planning a pregnancy. Therefore, the risk of having a child suffering from a genetic condition is largely eliminated. The SME is looking for partners to help them pioneer the technology in their clinical practice.... more

United Kingdom

Japanese start-up looking for partners for their naturally-derived anti-fungal drug for foot disease.

performing pre-clinical studies where both acute toxicity and efficacy tests were cleared confirming therefore the compound therapeutic effects that are at least twice more efficient than the drugs actually on... more


Novel therapeutic approach in a multiplicity of neurodegenerative and autoinflammatory pathologies

numerous caspase-1 inhibitors have been synthesized, no inhibitor has passed the clinical trial, probably because of the covalent mechanism of action and the consequent unwanted off-target interactions. The research... more


UK-based SME offers its mental health care pathway service to clinicians

therapeutic interventions with the latest digital solutions in a secure, user friendly web-based environment. It uses a blended approach where therapeutic interventions are supported by online tools and clinical... more

United Kingdom

Spinal cord injury regeneration using a marine bio-based hydrogel to be transfered from a French Technology Transfer Office.

indication. Until now, only a few materials are under research investigation. Moreover, such results haven't reached the clinical milestone yet because of an obvious major issue : it is strongly difficult to set... more


Novel drugs for the treatment of aging-related diseases like chronic wounds, glaucoma, skin fibrosis and skin-aging.

pressing need for innovative treatments. Based on preclinical studies on vascular smooth muscle cells, isolated organ studies and animal models, the low molecular weight clinical candidate of the Swiss biotech... more


The right partner not here?

Get in touch and we'll help you post a partnering opportunity